Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dexcom (DXCM) Other Non-Current Assets (2016 - 2025)

Dexcom (DXCM) has disclosed Other Non-Current Assets for 15 consecutive years, with $88.2 million as the latest value for Q3 2024.

  • On a quarterly basis, Other Non-Current Assets changed N/A to $88.2 million in Q3 2024 year-over-year; TTM through Sep 2024 was $88.2 million, a N/A change, with the full-year FY2023 number at $75.0 million, up 59.24% from a year prior.
  • Other Non-Current Assets was $88.2 million for Q3 2024 at Dexcom, up from $75.0 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $88.2 million in Q3 2024 to a low of $10.5 million in Q4 2021.
  • A 5-year average of $32.0 million and a median of $22.8 million in 2022 define the central range for Other Non-Current Assets.
  • Peak YoY movement for Other Non-Current Assets: crashed 50.93% in 2021, then soared 348.57% in 2022.
  • Dexcom's Other Non-Current Assets stood at $21.4 million in 2020, then plummeted by 50.93% to $10.5 million in 2021, then skyrocketed by 348.57% to $47.1 million in 2022, then skyrocketed by 59.24% to $75.0 million in 2023, then increased by 17.6% to $88.2 million in 2024.
  • Per Business Quant, the three most recent readings for DXCM's Other Non-Current Assets are $88.2 million (Q3 2024), $75.0 million (Q4 2023), and $47.1 million (Q4 2022).